As I previously said I have not been following PTX due to the trial halt.I did speak to Steven just before christmas after not speaking to him for over a year...these are the main points;
It seems that a lot on news will be coming out on many fronts about mid year...I did ask him about the timeframe "soon"which was mentioned on the breast cancer resuming trial on the 11 December...maybe difficult to exactly say so no time period was clarified.
He was very happy about the resumption of all the trials and the FDA has an enormous respect for our scientific team...it seemed like our brightest brains eclipsed anything that they had in their organisation.
He also mentioned that there is tremendous amount of market interest in our new drug PTX 100 and quoted in our PTX update
"We are tremendously excited about this program - it is potentially transformative for Prescient.”
Personally I can see SP action starting well before the middle of the year...Steven was in the States although I am not sure why but US investors know it is ridiculously undervalued ...it just needs a catalyst to start it off
PTX Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
